Payment overview · 2025
General Payments
$800.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Sara Cobb, PA
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · ASHEVILLE, NC · NPI 1801349279
Verified facts
What the public records show
CMS Open Payments records show Sara Cobb, PA received $800.00 in general payments during 2025 across 1 reported records.
Autolus Inc accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Autolus Inc | Unresolved — no canonical attribution shown | $800.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Honoraria | $800.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 448 | 141 |
| Lisinopril | Lisinopril | 346 | 108 |
| Levothyroxine Sodium | Levothyroxine Sodium | 340 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 300 | 96 |
| Omeprazole | Omeprazole | 234 | 75 |
| Losartan Potassium | Losartan Potassium | 213 | 63 |
| Tramadol Hcl | Tramadol Hcl | 181 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 178 | 62 |
| Simvastatin | Simvastatin | 175 | 55 |
| Alprazolam | Alprazolam | 170 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 142 | 27 |
| Metformin Hcl | Metformin Hcl | 125 | 49 |
| Hydrochlorothiazide | Hydrochlorothiazide | 121 | 46 |
| Trazodone Hcl | Trazodone Hcl | 120 | 35 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 116 | 41 |
| Gabapentin | Gabapentin | 112 | 37 |
| Potassium Chloride | Potassium Chloride | 111 | 40 |
| Furosemide | Furosemide | 106 | 35 |
| Sertraline Hcl | Sertraline Hcl | 106 | 42 |
| Eliquis | Apixaban | 98 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 97 | 28 |
| Montelukast Sodium | Montelukast Sodium | 97 | 34 |
| Lorazepam | Lorazepam | 94 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 92 | 29 |
| Spironolactone | Spironolactone | 89 | 28 |
| Citalopram Hbr | Citalopram Hydrobromide | 84 | 25 |
| Famotidine | Famotidine | 83 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 83 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 77 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 76 | 34 |
| Clonazepam | Clonazepam | 75 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 68 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 64 | 21 |
| Bupropion Xl | Bupropion Hcl | 63 | 20 |
| Jardiance | Empagliflozin | 62 | 21 |
| Ozempic | Semaglutide | 57 | 13 |
| Synthroid | Levothyroxine Sodium | 57 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 14 |
| Allopurinol | Allopurinol | 49 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 49 | 14 |
| Baclofen | Baclofen | 48 | 16 |
| Temazepam | Temazepam | 46 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 46 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 15 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 45 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 12 |
| Meloxicam | Meloxicam | 43 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | 11 |
| Atenolol | Atenolol | 38 | 11 |
| Pregabalin | Pregabalin | 38 | suppressed |
| Xarelto | Rivaroxaban | 38 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 36 | 13 |
| Nystatin | Nystatin | 34 | 15 |
| Buspirone Hcl | Buspirone Hcl | 33 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 33 | 17 |
| Glipizide Er | Glipizide | 33 | 11 |
| Metformin Hcl Er | Metformin Hcl | 33 | 14 |
| Carvedilol | Carvedilol | 32 | suppressed |
| Celecoxib | Celecoxib | 32 | suppressed |
| Trulicity | Dulaglutide | 32 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 31 | 11 |
| Irbesartan | Irbesartan | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 29 | suppressed |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Prednisone | Prednisone | 28 | 22 |
| Glimepiride | Glimepiride | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 25 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Azithromycin | Azithromycin | 23 | 22 |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 23 | suppressed |
| Fluconazole | Fluconazole | 23 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Klor-Con M20 | Potassium Chloride | 21 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 15 |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 20 |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 15 | suppressed |
| Eszopiclone | Eszopiclone | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Carisoprodol | Carisoprodol | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | 11 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $800.00 · 1 records | Autolus Inc | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error